Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente JOURNAL OF VIRAL HEPATITIS

Tipo Año Título Fuente
Artículo2023Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™JOURNAL OF VIRAL HEPATITIS
Artículo2022Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: data from the global liver registryJOURNAL OF VIRAL HEPATITIS
Artículo2021A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis CJOURNAL OF VIRAL HEPATITIS
Artículo2021Impact of recent drug use on the efficacy of Elbasvir/Grazoprevir for HCV-infected people on opioid agonist therapy.JOURNAL OF VIRAL HEPATITIS
Letter2021Optimal hepatitis B vaccination schedule for cirrhotic patients: a still unanswered questionJOURNAL OF VIRAL HEPATITIS
Artículo2019Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patientsJOURNAL OF VIRAL HEPATITIS
Artículo2019Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohortJOURNAL OF VIRAL HEPATITIS
Artículo2019Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfectionJOURNAL OF VIRAL HEPATITIS
Artículo2018Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patientsJOURNAL OF VIRAL HEPATITIS
Artículo2018Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohortJOURNAL OF VIRAL HEPATITIS
Artículo2017Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infectionJOURNAL OF VIRAL HEPATITIS
Artículo2017Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohortJOURNAL OF VIRAL HEPATITIS
Artículo2016Lymphomagenesis-related gene expression in B cells from sustained virological responders with occult hepatitis C virus infectionJOURNAL OF VIRAL HEPATITIS
Artículo2015Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in SpainJOURNAL OF VIRAL HEPATITIS
Artículo2015Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients ProgramJOURNAL OF VIRAL HEPATITIS
Resumen congreso2014Entecavir has high efficacy and safety in Caucasian patients with chronic hepatitis B and co-morbiditiesJOURNAL OF VIRAL HEPATITIS
Artículo2014Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitroJOURNAL OF VIRAL HEPATITIS
Artículo2014Impact of the peginterferon-alpha 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypesJOURNAL OF VIRAL HEPATITIS
Artículo2011Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patientsJOURNAL OF VIRAL HEPATITIS
Revisión2011Use of HOMA-IR in hepatitis CJOURNAL OF VIRAL HEPATITIS
Artículo2010Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patientsJOURNAL OF VIRAL HEPATITIS
Artículo2009HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapseJOURNAL OF VIRAL HEPATITIS
Artículo2009Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infectionJOURNAL OF VIRAL HEPATITIS
Letter2007Analysis of the -844C > T polymorphism in the promoter region of FASL gene in a cohort of Spanish HCV patientsJOURNAL OF VIRAL HEPATITIS
Artículo2007Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: A randomized trialJOURNAL OF VIRAL HEPATITIS
Artículo2006Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patientsJOURNAL OF VIRAL HEPATITIS
Artículo2005The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis CJOURNAL OF VIRAL HEPATITIS
Artículo2004Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using Real-time Polymerase Chain Reaction and Fluorescence Resonance Energy Transfer technologiesJOURNAL OF VIRAL HEPATITIS
Artículo2003COMPARATIVE STUDY OF THE EFFICACY OF AN INDUCTION DOSE OF INTERFERON-ALFA 2B WITH RIBAVIRIN COMPARED WITH STANDARD COMBINED TREATMENT IN NAIVE PATIENTS WITH CHRONIC HEPATITIS CJOURNAL OF VIRAL HEPATITIS
Artículo1994Predictive value of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C undergoing interferon‐α therapy. Analysis by two different methodsJOURNAL OF VIRAL HEPATITIS